AURIS MEDICAL (EARS)

[Triple9]

Thomson Reuters shows 2 BUY recommendations for $EARS, one with a 12 month price target of $4.00 and the other a target of $4.50.

Zachs also shows 2 BUY recommendation. Those reports are dated 10/4.

The one out today, 10/5, is from ValueEngine. It has $EARS as a strong sell based on it's proprietary ranking system which puts $EARS against other biotechs. In that system, biotechs with revenues are going to smash $EARS, and that's exactly why it's listed as a strong sell. Oddly, the report lists 1 STRONG BUY recommendation. Wish they showed the names of the firms.

Anyway, nice to see any coverage of $EARS at all. No one was covering for a long while.